Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment. (Q37443878)
Jump to navigation
Jump to search
scientific article published on March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment. |
scientific article published on March 2009 |
Statements
Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment (English)
1 reference
Katerina Bouchalova